GlassScriptPhysician profile
Nathan Holland
NPI 1679828651
$1,465.36
in general payments reported to CMS, 2019-2025
18 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $440 · 2023: $184 · 2024: $248 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.44 |
| Travel and Lodging | $257.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $384.65 | 2022-2025 | Vasoview Hemopro 2 |
| Atricure, INC. | $184.02 | 2022-2025 | Synergy Ablation System |
| Zimmer Biomet Holdings, INC. | $156.45 | 2022-2024 | Ribfix Blu Advantage |
| Prism Medical | $128.50 | 2024-2025 | |
| Depuy Synthes Sales INC. | $102.63 | 2021 | |
| Haemonetics Corporation | $80.09 | 2022 | |
| Edwards Lifesciences Corporation | $78.24 | 2023-2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $63.45 | 2023 | Camzyos |
| Ethicon US, LLC | $41.81 | 2025 | Stratafix |
| Medtronic, INC. | $39.48 | 2024 | Signia, Ligasure |
| Hologic Sales and Service, LLC | $34.78 | 2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.83 | 2021-2024 | Lifevest |
| Bolton Medical INC | $26.54 | 2024 | Treo Abdominal Stent-Graft System |
| Davol INC. | $26.40 | 2023 | |
| Octapharma USA, INC. | $25.20 | 2025 | Fibryga |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $25.00 | 2024 | Tagrisso |
| Medela LLC | $22.81 | 2025 | Thopaz |
| Regeneron Healthcare Solutions, INC. | $16.48 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.